Stay inspired, stay innovative, stay inventive, and stay in building a healthier world

Snibe has always aimed to providing better in vitro diagnostics (IVD) solutions to the world. Upholding the motto Quality is our life, as a premier IVD manufacturer, we are dedicated to providing everyone with better healthcare. For over a decade, we have been persistently working toward building a healthier India.

India has always been the key market for Snibe. In the past few years, Snibe has established mature cooperative partnership with a variety of hospitals and laboratories across the country. We look forward to providing accessible healthcare for all.

Never-ceasing innovation
We constantly strive to expand new technologies as we believe that innovation is the most crucial component of research and development. In this era of prosperity in the medical field, adhering to innovation is not only a benign competition, but it can also promote scientific and technology development and advance global medical and healthcare.

In 2023, Snibe launched several innovative laboratory solutions that have the ability to significantly improve detected automation, operated efficiency, test result reliability, and cost-effectiveness:

MAGLUMI X Tech. This technology is applied in the state-of-the-art MAGLUMI X series fully-auto CLIA analyzers currently. With its outstanding features, laboratories now have access to more reliable and accurate testing results than ever before. MAGLUMI X Tech incorporates advanced patented pipetting technology, accurate incubation technology, exclusive intelligent washing technology, stable and accurate measuring chamber, pioneer in optional wash liquid preparation, and flexible expansion technology. Additionally, Snibe has launched the MAGLUMI X6 (450 T/H) in 2023, which bridges the gap between the super-high throughput analyzer MAGLUMI X8 (600 T/H) and the space-saving analyzer MAGLUMI X3 (200T/H), providing laboratories with more options to choose from, catering to the needs of different volume labs.

Biolumi CX8. It is an intelligent system that combines the super-high throughput CLIA analyzer MAGLUMI X8 (600 T/H), biochemical analyzer Biossays C8 (1600 T/H), and ISE unit. This integrated system integrates the advantages of MAGLUMI X8 and Biossays C8 and can be connected to a total laboratory automation system. The intelligent management system simplifies operational workflows, establishing a fully automated laboratory pipeline. With its exceptional throughput, Biolumi CX8 is an ideal solution for laboratories seeking to optimize workflow efficiency and detecting accuracy.

Molesicion S6 and R8. We have launched two new members to our molecular analyzer series, Molecision R8 and Molecision S6. Molecision R8 is an integrated qPCR system that combines nucleic acid extraction, pre-processing of reagent, amplification, and diagnostic. It achieves a seamless workflow for molecular detection and offers a simplified one-touch operation. On the other hand, Molecision S6 is an absolute quantification dPCR platform that enables precise nucleic acid testing. It boasts unparalleled sensitivity and accuracy.

Small molecule sandwich detection tech. Focusing on the global challenges in small molecule detection, Snibe has successfully overcome the technical hurdles in the preparation of monoclonal antibodies capable of recognizing antigen-antibody complexes. This breakthrough small molecule sandwich detection technology surpasses the limitations of competitive methods, while achieving consistency and accuracy comparable to LC-MS/MS. These advancements have greatly contributed to precision diagnostics, empowering healthcare professionals in their clinical decision-making processes.

In 2024 and beyond, we will continue releasing more innovative products and solutions, integrating AI, ML, big data, and cloud computing capabilities to provide comprehensive solutions and higher throughput analyzers for the medical customers. Our goal is to bring more medical opportunities to people worldwide.

Knowledge is for all
In 2023, Snibe remained committed to collaborating with renowned authoritative associations in organizing scientific symposiums and academic conferences. We invited numerous experts and doctors to share their latest research findings. These conferences serve as platforms to showcase our cutting-edge research and technology discoveries. We firmly believe that knowledge is a collective asset of humanity, which is why we have organized Snibe Day conferences multiple times to transmit and share knowledge extensively, fostering a robust and vibrant academic exchange environment.

To be the key partner
Snibe India is growing at an exceptional pace. In recent years, we have established a complete product supply chain to ensure the urgent needs of our customers. We have also set up local warehouses in many regions of India and offices in major cities, such as Delhi, Mumbai, and Hyderabad. With excellent customer service centers and after-sales feedback systems, we have completed the cooperation network between Snibe India and healthcare providers. It is an honor for Snibe India to establish partnerships with outstanding distributors, well-known hospitals, and authoritative organizations. Together, we strive to build a better healthcare environment and provide improved medical conditions for all.

Expected future, Snibe is continually committed to providing innovative and high-quality solutions to meet the evolving needs of the medical industry and contribute to a healthier world. With our better-healthcare mission, we strive to make healthcare accessible and affordable for all.